These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28849787)

  • 1. Therapy: Immunotherapy advance for T1DM.
    Greenhill C
    Nat Rev Endocrinol; 2017 Oct; 13(10):564. PubMed ID: 28849787
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy: Modified proinsulin to treat T1DM.
    Geach T
    Nat Rev Endocrinol; 2013 Sep; 9(9):503. PubMed ID: 23856817
    [No Abstract]   [Full Text] [Related]  

  • 3. Proinsulin-specific T regulatory cells may control immune responses in type 1 diabetes: implications for adoptive therapy.
    Gliwiński M; Iwaszkiewicz-Grześ D; Wołoszyn-Durkiewicz A; Tarnowska M; Żalińska M; Hennig M; Zielińska H; Dukat-Mazurek A; Zielkowska-Dębska J; Zieliński M; Jaźwińska-Curyłło A; Owczuk R; Jarosz-Chobot P; Bossowski A; Szadkowska A; Młynarski W; Marek-Trzonkowska N; Moszkowska G; Siebert J; Myśliwiec M; Trzonkowski P
    BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32098895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proinsulin multi-peptide immunotherapy induces antigen-specific regulatory T cells and limits autoimmunity in a humanized model.
    Gibson VB; Nikolic T; Pearce VQ; Demengeot J; Roep BO; Peakman M
    Clin Exp Immunol; 2015 Dec; 182(3):251-60. PubMed ID: 26206289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide-for type 1 diabetes.
    Nikolic T; Zwaginga JJ; Uitbeijerse BS; Woittiez NJ; de Koning EJ; Aanstoot HJ; Roep BO
    Lancet Diabetes Endocrinol; 2020 Jun; 8(6):470-472. PubMed ID: 32723484
    [No Abstract]   [Full Text] [Related]  

  • 6. Antigen-Specific Peptide Immunotherapy for Type 1 Diabetes: Proof of Safety, Hope for Efficacy.
    Coppieters K; von Herrath M
    Cell Metab; 2017 Oct; 26(4):595-597. PubMed ID: 28978425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting proinsulin-reactive CD8+ T cells: a new direction for type 1 diabetes treatment.
    Abreu JR; Roep BO
    Expert Rev Clin Immunol; 2013 Nov; 9(11):1001-3. PubMed ID: 24168405
    [No Abstract]   [Full Text] [Related]  

  • 8. Probing the Meaning of Persistent Propeptide Release in Type 1 Diabetes.
    Kahn SE; Templin AT; Hull RL; Verchere CB
    Diabetes Care; 2019 Feb; 42(2):183-185. PubMed ID: 30665962
    [No Abstract]   [Full Text] [Related]  

  • 9. Intramuscular delivery of a naked DNA plasmid encoding proinsulin and pancreatic regenerating III protein ameliorates type 1 diabetes mellitus.
    Hou WR; Xie SN; Wang HJ; Su YY; Lu JL; Li LL; Zhang SS; Xiang M
    Pharmacol Res; 2011 Apr; 63(4):320-7. PubMed ID: 21185938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut peptide hormones and pediatric type 1 diabetes mellitus.
    Huml M; Kobr J; Siala K; Varvařovská J; Pomahačová R; Karlíková M; Sýkora J
    Physiol Res; 2011; 60(4):647-58. PubMed ID: 21574763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinsulin C-peptide is an autoantigen in people with type 1 diabetes.
    So M; Elso CM; Tresoldi E; Pakusch M; Pathiraja V; Wentworth JM; Harrison LC; Krishnamurthy B; Thomas HE; Rodda C; Cameron FJ; McMahon J; Kay TWH; Mannering SI
    Proc Natl Acad Sci U S A; 2018 Oct; 115(42):10732-10737. PubMed ID: 30275329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA class I epitope discovery in type 1 diabetes: independent and reproducible identification of proinsulin epitopes of CD8 T cells--report of the IDS T Cell Workshop Committee.
    Pinkse GG; Boitard C; Tree TI; Peakman M; Roep BO
    Ann N Y Acad Sci; 2006 Oct; 1079():19-23. PubMed ID: 17130527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mimicry in type 1 diabetes mellitus revisited: T-cell clones to GAD65 peptides with sequence homology to Coxsackie or proinsulin peptides do not crossreact with homologous counterpart.
    Schloot NC; Willemen SJ; Duinkerken G; Drijfhout JW; de Vries RR; Roep BO
    Hum Immunol; 2001 Apr; 62(4):299-309. PubMed ID: 11295462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal and infant beta cell hormone concentrations in relation to type 1 diabetes risk.
    Stumpp C; Beyerlein A; Ziegler AG; Bonifacio E
    Pediatr Diabetes; 2014 Nov; 15(7):528-33. PubMed ID: 24552441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class I epitope discovery in type 1 diabetes.
    van Endert P; Hassainya Y; Lindo V; Bach JM; Blancou P; Lemonnier F; Mallone R
    Ann N Y Acad Sci; 2006 Oct; 1079():190-7. PubMed ID: 17130554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting proinsulin to local immune cells using an intradermal microneedle delivery system; a potential antigen-specific immunotherapy for type 1 diabetes.
    Arikat F; Hanna SJ; Singh RK; Vilela L; Wong FS; Dayan CM; Coulman SA; Birchall JC
    J Control Release; 2020 Jun; 322():593-601. PubMed ID: 32087298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proinsulin-a pathogenic autoantigen in type 1 diabetes.
    Narendran P; Mannering SI; Harrison LC
    Autoimmun Rev; 2003 Jun; 2(4):204-10. PubMed ID: 12848947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects.
    Oling V; Marttila J; Ilonen J; Kwok WW; Nepom G; Knip M; Simell O; Reijonen H
    J Autoimmun; 2005 Nov; 25(3):235-43. PubMed ID: 16263242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proinsulin autoantibodies are more closely associated with type 1 (insulin-dependent) diabetes mellitus than insulin autoantibodies.
    Böhmer K; Keilacker H; Kuglin B; Hübinger A; Bertrams J; Gries FA; Kolb H
    Diabetologia; 1991 Nov; 34(11):830-4. PubMed ID: 1769442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes.
    Rudy G; Stone N; Harrison LC; Colman PG; McNair P; Brusic V; French MB; Honeyman MC; Tait B; Lew AM
    Mol Med; 1995 Sep; 1(6):625-33. PubMed ID: 8529129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.